 |
Bispecific antibody 520c9x22 |
|---|---|
| Trade Name | |
| Orphan Indication | For in vivo serotherapy of patients with ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 1993-10-05 00:00:00 |
| Sponsor | Medarex, Inc.;519 Route 173 West;Bloomsbury, New Jersey, 08804 |
| |
Bispecific antibody 520c9x22 |
|---|---|
| Trade Name | |
| Orphan Indication | For in vivo serotherapy of patients with ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 1993-10-05 00:00:00 |
| Sponsor | Medarex, Inc.;519 Route 173 West;Bloomsbury, New Jersey, 08804 |